Ibritumomab Intravenous and Pasireotide Injection
Determining the interaction of Ibritumomab Intravenous and Pasireotide Injection and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: pasireotide
Brand name: Signifor, Signifor LAR
Synonyms: Pasireotide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Pasireotide Subcutaneous
- Ibritumomab Intravenous-Patanase
- Ibritumomab Intravenous-Patiromer
- Ibritumomab Intravenous-Patiromer Sorbitex Calcium
- Ibritumomab Intravenous-Pavacot
- Ibritumomab Intravenous-Paxil
- Pasireotide Injection-Ibritumomab Tiuxetan
- Pasireotide Injection-Ibrutinib
- Pasireotide Injection-Ibrutinib Capsules
- Pasireotide Injection-Ibrutinib Tablets
- Pasireotide Injection-Ibu
- Pasireotide Injection-IBU Tablets